Vanguard Fiduciary Trust
CATX icon

Vanguard Fiduciary Trust’s Perspective Therapeutics CATX Stock Holding History

Vanguard Fiduciary Trust’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.01M Buy
589,003
+22,327
+4% +$84.3K ﹤0.01% 2665
2026
Q1 		$2.36M Buy
+566,676
New +$2.39M ﹤0.01% 2475

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Vanguard Fiduciary Trust's CATX Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Perspective Therapeutics (CATX) stake by 3.9% in Q2 2026, buying an estimated $84.3K and bringing the position to 589,003 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2665.

Vanguard Fiduciary Trust first reported a position in CATX in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.36M in Q1 2026. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Vanguard Fiduciary Trust held 589,003 shares of Perspective Therapeutics worth $2.01M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 22,327 Perspective Therapeutics shares in Q2 2026, an estimated $84.3K.
  • Perspective Therapeutics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2665 holding.
  • Vanguard Fiduciary Trust first reported a position in Perspective Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Perspective Therapeutics position peaked at $2.36M in Q1 2026.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.